fulvestrant has been researched along with thyroxine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, T; Forman, BM; Lin, W; Yu, DD | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Cao, JH; Davis, FB; Davis, PJ; Hercbergs, A; Lin, HY; London, D; Luidens, M; Meng, R; Mousa, SA; Tang, HY; Westfall, J | 1 |
1 review(s) available for fulvestrant and thyroxine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for fulvestrant and thyroxine
| Article | Year |
|---|---|
Development of time resolved fluorescence resonance energy transfer-based assay for FXR antagonist discovery.
Topics: Biological Assay; Drug Discovery; Fluoresceins; Fluorescence Resonance Energy Transfer; Fluorescent Dyes; Gene Expression Regulation; Isoxazoles; Molecular Structure; Protein Binding; Receptors, Cytoplasmic and Nuclear | 2013 |
Crosstalk between integrin αvβ3 and estrogen receptor-α is involved in thyroid hormone-induced proliferation in human lung carcinoma cells.
Topics: Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Enzyme Activation; Estradiol; Estrogen Receptor alpha; Extracellular Signal-Regulated MAP Kinases; Fulvestrant; Humans; Integrin alphaVbeta3; Lung Neoplasms; Phosphorylation; Proliferating Cell Nuclear Antigen; Protein Transport; Signal Transduction; Thyroid Hormones; Thyroxine | 2011 |